Phase I Study of Mogamulizumab in Combination with Pembrolizumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma—A National Cancer Institute Experimental Therapeutics Clinical Trials Network (NCI-ETCTN) Trial. - Joffe, Erel; Kumar, Anita; Tuscano, Joseph M.; Moskowitz, Alison J.; Owens, Colette; Noy, Ariela; Palomba, Maria Lia; Zelenetz, Andrew D.; Ni, Andy; Sharon, Elad; Vardhana, Santosha (Cancers, 2026)